Exosomal FOXL1 from bone marrow mesenchymal stem cells activates the METTL3/ATXN2L pathway to ameliorate high glucose-induced human retinal microvascular endothelial cell injury.
Saved in:
| Title: | Exosomal FOXL1 from bone marrow mesenchymal stem cells activates the METTL3/ATXN2L pathway to ameliorate high glucose-induced human retinal microvascular endothelial cell injury. |
|---|---|
| Authors: | Niu, Chao1 (AUTHOR) 19937671631@163.com, Dong, Daoquan1 (AUTHOR), Cui, Longjiang1 (AUTHOR), Dong, Yingli1 (AUTHOR), Wang, Wei2 (AUTHOR) |
| Source: | Diabetology & Metabolic Syndrome. 6/18/2025, Vol. 17 Issue 1, p1-13. 13p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
